MichaelEndrodi(Dohnanyi)SalaczMD
Oncology • Pennington, NJNeuro-Oncology
Director, Neuro-Oncology Program Associate Professor of Medicine Rutgers, Cancer Institute of New Jersey Robert Wood Johnson Medical School
Dr. Salacz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Capital Way
Pennington, NJ 08534Phone+1 609-537-6363
Summary
- Dr. Michael Salacz is a neuro-oncologist in Hopewell, NJ and Camden, NJ and is affiliated with Capital Health, Hopewell as well as Cooper Health, Camden. He received his medical degree from Rutgers - New Jersey Medical School and has been in practice 19 years. He specializes in neuro-oncology and is experienced in oligodendroglioma, ependymoma, primary central nervous system lymphoma, neuroblastoma, and glioblastoma multiforme. He has more than 20 publications and over 500 citations.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1999 - 2002- University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1998 - 1999
Rutgers New Jersey Medical SchoolClass of 1998
Certifications & Licensure
NJ State Medical License 2020 - 2025
KS State Medical License 2005 - 2021
MO State Medical License 2005 - 2021
NC State Medical License 2007 - 2008
WI State Medical License 2002 - 2005
OH State Medical License 2000 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- 1 citationsVirtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.James L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, Lisa Boris, Yeonju Kim
Journal of Neuro-Oncology. 2024-04-01 - 3 citationsAn expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs
CNS Oncology. 2023-09-01 - 175 citationsAssociation of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim
JAMA Oncology. 2023-01-01
Journal Articles
- Profiles of Brain Metastases: Prioritization of Therapeutic TargetsRaymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
Press Mentions
8 Oncologists on the MoveApril 2nd, 2021- Rutgers Cancer Institute of New Jersey Names Director of Neuro-OncologyMarch 24th, 2021
John McCain Has Died. For Brain Cancers like His, 'Research Is Our Only Hope'August 25th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
